This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Credit Suisse (CS) to Own 100% of China Securities Joint Venture
by Zacks Equity Research
Credit Suisse (CS) enters a deal to buy its 49% stake in its China securities JV from Founder Securities, following which it will have full ownership of its onshore securities venture.
FDIC-Insured Banks' Q2 Earnings Dip on High Provisions, NIM Up
by Swayta Shah
Rise in provisions and an increase in expenses hurt FDIC-insured banks' Q2 earnings. Yet, major banks like JPMorgan (JPM), Bank of America (BAC), Citigroup (C) & Wells Fargo (WFC) get support from the higher rates and decent loan demand.
Company News for Sep 9, 2022
by Zacks Equity Research
Companies in The News Are: REGN, JPM, CASY, GME
Keep JPMorgan (JPM) on Your Radar Despite the 27% YTD Slide
by Swayta Shah
JPMorgan (JPM) stock is worth keeping an eye on despite its 27% decline. Asset-sensitive balance sheet, rising loan demand, its industry-leading franchises in several businesses and plans for technological advancement offers decent upside potential.
Zacks Earnings Trends Highlights: JPMorgan, Oracle, Costco and FedEx
by Zacks Equity Research
JPMorgan, Oracle, Costco and FedEx are part of Zacks Earnings Trends article.
Previewing the Q3 Earnings Season as Estimates Slide
by Sheraz Mian
Estimates for the last two quarters of this year and full-year 2023 are coming down, even though positive revisions to the Energy sector continue to partly offset those estimate cuts elsewhere.
Previewing the Q3 Earnings Season as Estimates Slide
by Sheraz Mian
Estimates for the last two quarters of this year and full-year 2023 are coming down, even though positive revisions to the Energy sector continue to partly offset those estimate cuts elsewhere.
JPMorgan Chase & Co. (JPM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
JPMorgan Chase & Co. (JPM) closed the most recent trading day at $113.74, moving +0.03% from the previous trading session.
JPMorgan (JPM) Plans Hiring in Germany Amid Retail Expansion
by Zacks Equity Research
JPMorgan (JPM) plans to hire bankers in Germany as it prepares to expand its international consumer business.
JPMorgan Chase & Co. (JPM) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to JPMorgan Chase & Co. (JPM). This makes it worthwhile to examine what the stock has in store.
Should Vanguard High Dividend Yield ETF (VYM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VYM
JPMorgan Chase & Co. (JPM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
JPMorgan Chase & Co. (JPM) closed at $114.41 in the latest trading session, marking a +0.02% move from the prior day.
Citi (C) to Incur $170M Charges on Exit From Russian Operations
by Zacks Equity Research
Citigroup (C) announces exit from Russian consumer banking and commercial banking operations. This will result in $170 million in charges, which will be incurred over the span of 18 months.
JPMorgan Chase & Co. (JPM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
JPMorgan Chase & Co. (JPM) closed the most recent trading day at $115.80, moving +0.24% from the previous trading session.
Financials ETFs: Can the Rebound Continue?
by Neena Mishra
Bank stocks had taken a beating earlier this year due to recession fears
The Zacks Analyst Blog Highlights JPMorgan Chase, AbbVie, Abbott Laboratories, Intuit and Caterpillar
by Zacks Equity Research
JPMorgan Chase, AbbVie, Abbott Laboratories, Intuit and Caterpillar are included in this Analyst Blog.
JPMorgan Chase & Co. (JPM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
JPMorgan Chase & Co. (JPM) closed at $121.64 in the latest trading session, marking a -0.77% move from the prior day.
Top Analyst Reports for JPMorgan Chase, AbbVie & Abbott
by Sheraz Mian
Today's Research Daily features new research reports on 12 major stocks, including JPMorgan Chase & Co. (JPM), AbbVie Inc. (ABBV) and Abbott Laboratories (ABT).
JPMorgan Chase & Co. (JPM) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching JPMorgan Chase & Co. (JPM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Fed Issues Guidelines for Banks Engaging in Crypto Activities
by Nikita Kataruka
Banks like JPMorgan (JPM), Citigroup (C), Goldman Sachs (GS) and many others seeking to engage in crypto activities need to follow the guidance recently issued by the Fed.
JPMorgan (JPM) Closes Buyout of Ireland-Based Global Shares
by Zacks Equity Research
To improve product suite and digitize operations outside the United States, JPMorgan (JPM) acquires fintech firm Global Shares.
Morgan Stanley (MS) Agrees to Pay $200M to Resolve SEC's Probe
by Zacks Equity Research
Morgan Stanley (MS) agrees to pay a fine of $200 million to the SEC and the CFTC to resolve investigations into its record-keeping practices.
Investors Heavily Search JPMorgan Chase & Co. (JPM): Here is What You Need to Know
by Zacks Equity Research
JPMorgan Chase & Co. (JPM) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Banking Earnings Downbeat: What's in Store for ETFs?
by Sanghamitra Saha
Only two out of six big U.S. banks was able to beat overall this earnings season.
F.N.B. Corp (FNB) Stock Up on Q2 Earnings Beat, Costs Rise Y/Y
by Zacks Equity Research
F.N.B. Corp (FNB) records a rise in revenues and expenses in the second quarter of 2022.